Shanghai Shyndec Pharmaceutical Statistics

Total Valuation

Shanghai Shyndec Pharmaceutical has a market cap or net worth of CNY 14.00 billion. The enterprise value is 10.78 billion.

Market Cap	14.00B
Enterprise Value	10.78B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 18, 2024

Share Statistics

Shanghai Shyndec Pharmaceutical has 1.34 billion shares outstanding. The number of shares has increased by 12.95% in one year.

Shares Outstanding	1.34B
Shares Change (YoY)	+12.95%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	1.31%
Owned by Institutions (%)	5.39%
Float	534.88M

Valuation Ratios

The trailing PE ratio is 13.14 and the forward PE ratio is 10.88. Shanghai Shyndec Pharmaceutical's PEG ratio is 0.35.

PE Ratio	13.14
Forward PE	10.88
PS Ratio	1.21
PB Ratio	1.08
P/FCF Ratio	6.00
PEG Ratio	0.35

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.79, with an EV/FCF ratio of 4.62.

EV / Earnings	10.12
EV / Sales	0.93
EV / EBITDA	4.79
EV / EBIT	7.52
EV / FCF	4.62

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 7.40.

Current Ratio	2.46
Quick Ratio	1.80
Debt / Equity	7.40
Debt / EBITDA	0.50
Debt / FCF	0.48
Interest Coverage	71.25

Financial Efficiency

Return on equity (ROE) is 9.20% and return on invested capital (ROIC) is 5.73%.

Return on Equity (ROE)	9.20%
Return on Assets (ROA)	4.61%
Return on Capital (ROIC)	5.73%
Revenue Per Employee	998,061
Profits Per Employee	91,783
Employee Count	11,608
Asset Turnover	0.60
Inventory Turnover	3.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.88% in the last 52 weeks. The beta is 0.17, so Shanghai Shyndec Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+5.88%
50-Day Moving Average	11.81
200-Day Moving Average	10.42
Relative Strength Index (RSI)	25.03
Average Volume (20 Days)	11,157,426

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Shyndec Pharmaceutical had revenue of CNY 11.59 billion and earned 1.07 billion in profits. Earnings per share was 0.79.

Revenue	11.59B
Gross Profit	4.40B
Operating Income	1.43B
Pretax Income	1.57B
Net Income	1.07B
EBITDA	2.23B
EBIT	1.43B
Earnings Per Share (EPS)	0.79

Full Income Statement

Balance Sheet

The company has 6.45 billion in cash and 1.12 billion in debt, giving a net cash position of 5.34 billion or 3.98 per share.

Cash & Cash Equivalents	6.45B
Total Debt	1.12B
Net Cash	5.34B
Net Cash Per Share	3.98
Equity (Book Value)	15.09B
Book Value Per Share	9.67
Working Capital	6.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.63 billion and capital expenditures -293.45 million, giving a free cash flow of 2.33 billion.

Operating Cash Flow	2.63B
Capital Expenditures	-293.45M
Free Cash Flow	2.33B
FCF Per Share	1.74

Full Cash Flow Statement

Margins

Gross margin is 38.01%, with operating and profit margins of 12.38% and 9.20%.

Gross Margin	38.01%
Operating Margin	12.38%
Pretax Margin	13.51%
Profit Margin	9.20%
EBITDA Margin	19.24%
EBIT Margin	12.38%
FCF Margin	20.13%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.96%.

Dividend Per Share	0.10
Dividend Yield	0.96%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	27.77%
Buyback Yield	-12.95%
Shareholder Yield	-11.99%
Earnings Yield	7.61%
FCF Yield	16.66%

Dividend Details

Stock Splits

The last stock split was on May 25, 2017. It was a forward split with a ratio of 2.

Last Split Date	May 25, 2017
Split Type	Forward
Split Ratio	2